LncRNA cancer susceptibility candidate 11 (CASC11), an oncogene, is overexpressed in HCC tissues and cells and decreases the m6A level of UBE2T via recruiting ALKBH5 (66). This evidence concerns the gene CASC11 and hepatocellular carcinoma.